CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis

OSL:CONTX • SE0014731154

3 NOK
+0.03 (+1.01%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

5

CONTX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 11 industry peers in the Health Care Technology industry. CONTX has an average financial health and profitability rating. CONTX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CONTX had positive earnings in the past year.
  • In the past year CONTX had a positive cash flow from operations.
  • Of the past 5 years CONTX 4 years were profitable.
  • CONTX had a positive operating cash flow in each of the past 5 years.
CONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFCONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

1.2 Ratios

  • CONTX has a Return On Assets (0.61%) which is comparable to the rest of the industry.
  • CONTX has a Return On Equity (0.83%) which is comparable to the rest of the industry.
  • The Return On Invested Capital of CONTX (0.30%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CONTX is significantly above the industry average of 8.07%.
  • The last Return On Invested Capital (0.30%) for CONTX is well below the 3 year average (20.44%), which needs to be investigated, but indicates that CONTX had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.61%
ROE 0.83%
ROIC 0.3%
ROA(3y)16.48%
ROA(5y)14.4%
ROE(3y)23.03%
ROE(5y)18.42%
ROIC(3y)20.44%
ROIC(5y)37.45%
CONTX.OL Yearly ROA, ROE, ROICCONTX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.69%, CONTX is in line with its industry, outperforming 54.55% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CONTX has declined.
  • CONTX has a Operating Margin (0.36%) which is comparable to the rest of the industry.
  • CONTX's Operating Margin has declined in the last couple of years.
  • CONTX has a Gross Margin of 97.37%. This is amongst the best in the industry. CONTX outperforms 90.91% of its industry peers.
  • In the last couple of years the Gross Margin of CONTX has remained more or less at the same level.
Industry RankSector Rank
OM 0.36%
PM (TTM) 0.69%
GM 97.37%
OM growth 3Y-77.87%
OM growth 5Y-62.43%
PM growth 3Y-69.2%
PM growth 5Y-43.82%
GM growth 3Y-1.24%
GM growth 5Y-0.07%
CONTX.OL Yearly Profit, Operating, Gross MarginsCONTX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80 100

5

2. Health

2.1 Basic Checks

  • CONTX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for CONTX remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for CONTX remains at a similar level compared to 5 years ago.
  • Compared to 1 year ago, CONTX has a worse debt to assets ratio.
CONTX.OL Yearly Shares OutstandingCONTX.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CONTX.OL Yearly Total Debt VS Total AssetsCONTX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • CONTX has a debt to FCF ratio of 62.32. This is a negative value and a sign of low solvency as CONTX would need 62.32 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 62.32, CONTX perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
  • A Debt/Equity ratio of 0.10 indicates that CONTX is not too dependend on debt financing.
  • CONTX has a Debt to Equity ratio of 0.10. This is in the better half of the industry: CONTX outperforms 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 62.32
Altman-Z N/A
ROIC/WACC0.04
WACC6.99%
CONTX.OL Yearly LT Debt VS Equity VS FCFCONTX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • CONTX has a Current Ratio of 4.28. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • CONTX's Current ratio of 4.28 is amongst the best of the industry. CONTX outperforms 90.91% of its industry peers.
  • CONTX has a Quick Ratio of 4.23. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • CONTX's Quick ratio of 4.23 is amongst the best of the industry. CONTX outperforms 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 4.28
Quick Ratio 4.23
CONTX.OL Yearly Current Assets VS Current LiabilitesCONTX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

  • The earnings per share for CONTX have decreased strongly by -96.77% in the last year.
  • Measured over the past years, CONTX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -41.36% on average per year.
  • The Revenue for CONTX has decreased by -15.61% in the past year. This is quite bad
  • CONTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.08% yearly.
EPS 1Y (TTM)-96.77%
EPS 3Y-69.6%
EPS 5Y-41.36%
EPS Q2Q%-42.87%
Revenue 1Y (TTM)-15.61%
Revenue growth 3Y-2.18%
Revenue growth 5Y3.08%
Sales Q2Q%-7.27%

3.2 Future

  • CONTX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 400.00% yearly.
  • Based on estimates for the next years, CONTX will show a small growth in Revenue. The Revenue will grow by 2.70% on average per year.
EPS Next Y1200%
EPS Next 2Y400%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.66%
Revenue Next 2Y3.7%
Revenue Next 3Y6.52%
Revenue Next 5Y2.7%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CONTX.OL Yearly Revenue VS EstimatesCONTX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M
CONTX.OL Yearly EPS VS EstimatesCONTX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4 0.5

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 300.00, the valuation of CONTX can be described as expensive.
  • CONTX's Price/Earnings ratio is in line with the industry average.
  • CONTX is valuated expensively when we compare the Price/Earnings ratio to 27.07, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 25.19 indicates a quite expensive valuation of CONTX.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CONTX.
  • CONTX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 300
Fwd PE 25.19
CONTX.OL Price Earnings VS Forward Price EarningsCONTX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, CONTX is valued a bit more expensive than the industry average as 63.64% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 1093.27
EV/EBITDA N/A
CONTX.OL Per share dataCONTX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CONTX may justify a higher PE ratio.
  • CONTX's earnings are expected to grow with 400.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y400%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
  • The stock price of CONTX dropped by -28.06% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • CONTX's Dividend Yield is rather good when compared to the industry average which is at 2.31. CONTX pays more dividend than 81.82% of the companies in the same industry.
  • CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y400%
EPS Next 3YN/A
CONTX.OL Yearly Income VS Free CF VS DividendCONTX.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

CONTEXTVISION AB

OSL:CONTX (2/27/2026, 7:00:00 PM)

3

+0.03 (+1.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-19
Earnings (Next)05-08
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap232.11M
Revenue(TTM)110.28M
Net Income(TTM)762.00K
Analysts40
Price Target4.08 (36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-15.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.74%
Valuation
Industry RankSector Rank
PE 300
Fwd PE 25.19
P/S 2
P/FCF 1093.27
P/OCF 49.73
P/B 2.4
P/tB 2.46
EV/EBITDA N/A
EPS(TTM)0.01
EY0.33%
EPS(NY)0.12
Fwd EY3.97%
FCF(TTM)0
FCFY0.09%
OCF(TTM)0.06
OCFY2.01%
SpS1.5
BVpS1.25
TBVpS1.22
PEG (NY)0.25
PEG (5Y)N/A
Graham Number0.53
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 0.83%
ROCE 0.39%
ROIC 0.3%
ROICexc 0.96%
ROICexgc 1.03%
OM 0.36%
PM (TTM) 0.69%
GM 97.37%
FCFM 0.18%
ROA(3y)16.48%
ROA(5y)14.4%
ROE(3y)23.03%
ROE(5y)18.42%
ROIC(3y)20.44%
ROIC(5y)37.45%
ROICexc(3y)77.73%
ROICexc(5y)111.49%
ROICexgc(3y)103.93%
ROICexgc(5y)184.88%
ROCE(3y)26.61%
ROCE(5y)48.75%
ROICexgc growth 3Y-81.88%
ROICexgc growth 5Y-66.49%
ROICexc growth 3Y-79.52%
ROICexc growth 5Y-59.81%
OM growth 3Y-77.87%
OM growth 5Y-62.43%
PM growth 3Y-69.2%
PM growth 5Y-43.82%
GM growth 3Y-1.24%
GM growth 5Y-0.07%
F-Score5
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 62.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 3.84%
Interest Coverage 0.99
Cash Conversion N/A
Profit Quality 26.51%
Current Ratio 4.28
Quick Ratio 4.23
Altman-Z N/A
F-Score5
WACC6.99%
ROIC/WACC0.04
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.73%
Cap/Sales(5y)4.01%
Profit Quality(3y)87.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.77%
EPS 3Y-69.6%
EPS 5Y-41.36%
EPS Q2Q%-42.87%
EPS Next Y1200%
EPS Next 2Y400%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.61%
Revenue growth 3Y-2.18%
Revenue growth 5Y3.08%
Sales Q2Q%-7.27%
Revenue Next Year5.66%
Revenue Next 2Y3.7%
Revenue Next 3Y6.52%
Revenue Next 5Y2.7%
EBIT growth 1Y-98.68%
EBIT growth 3Y-78.36%
EBIT growth 5Y-61.27%
EBIT Next Year3400%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-99.31%
FCF growth 3Y-78.75%
FCF growth 5Y-57.02%
OCF growth 1Y-86.52%
OCF growth 3Y-44.44%
OCF growth 5Y-27.59%

CONTEXTVISION AB / CONTX.OL FAQ

What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.


What is the valuation status for CONTX stock?

ChartMill assigns a valuation rating of 3 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.


What is the profitability of CONTX stock?

CONTEXTVISION AB (CONTX.OL) has a profitability rating of 6 / 10.


What is the financial health of CONTEXTVISION AB (CONTX.OL) stock?

The financial health rating of CONTEXTVISION AB (CONTX.OL) is 5 / 10.


What is the expected EPS growth for CONTEXTVISION AB (CONTX.OL) stock?

The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to grow by 1200% in the next year.